EXHIBIT

Enterprise Startup

CONVERGING THE MOST INFLUENTIAL ECOSYSTEM TO ACCELERATE INNOVATION AND INVESTMENT IN
LONGEVITY, BIOTECH AND HEALTH TECH

Name: LIVX 2026
Location: Dubai

THE WORLD’S NEXT AI-POWERED HEALTH ECONOMY STARTS HERE

Biotech. Life Sciences. Longevity. Age Tech. One global platform.

LIVX is a first-of-its-kind global platform uniting the full healthcare ecosystem from biotech and life sciences to longevity, AI and Age Tech.

Designed to break silos, LIVX connects innovators with regulators, investors, healthcare systems, and global markets to accelerate validation, partnerships, and scale.

JOIN THE ECOSYSTEM GET YOUR PASS

PROUDLY BACKED BY INDUSTRY LEADERS

Global Healthy Longevity Partner

THE NEXT HEALTH FRONTIER HAS A NEW GLOBAL DESTINATION

+

Global Delegates

+

Participating Countries

+

Exhibiting Companies

+

Global Investors

+

Government and Regulatory Entities Hosted Alongside GITEX Global

GET YOUR TICKET

THE VOICES DEFINING THE NEXT CENTURY OF HEALTH

Global leaders on the science that will shape how we live.

Trevor Martin

Co-founder and CEO

Mammoth Biosciences, USA

Dr. Alex Alipar

Co-Founder and President

Insilico Medicine, Hong Kong

Jeanne Lim

Founder and CEO

beingAI Corporation, USA

H.E. Dr. Maryam Matar

Founder & Chairperson

UAE Genetic Diseases Association, UAE

Dr. Craig Willcox

Co-principal Investigator and Head of Research Development

Okinawa Research Center for Longevity Science, Japan

Dr. Aubrey de Grey

President and CEO

LEV Foundation, USA

Dr. Nicole Sirotin

CEO

Institute of Healthier Living Abu Dhabi, UAE

Dr. Eric Verdin

President and CEO

Buck Institute for Research on Aging

Phil Newman

Founder & CEO

Longevity.Technology, UK

Charles-Edouard Bouée

Co-Founder and Managing Partner

Adagia Partners, France

Manjit Sareen

Head

Longevity Clinics World, UK

GET YOUR PASS

Four Sectors. One Connected Health Ecosystem.

Are you capturing global opportunities fast enough?

Biotech

Accelerating next-generation therapeutics, biologics, and gene-based solutions — from discovery to market readiness.

Biotech market in GCC to hit US$ 2.6B by 2028, led by UAE & KSA

Life Sciences

Advancing diagnostics, genomics, clinical research, and AI-enabled healthcare systems.

Life Sciences market size Worth US$ 278B by 2034.

Longevity

Translating science into healthspan - regenerative medicine, preventive health, and longevity innovation.

Longevity Solutions in GCC expected to reach US$ 126B by 2033

AI & Age Tech

Rapid growth driven by aging populations, preventive care demand, and AI-enabled personalization

The market for Age Tech could grow to US$ 2T

The Next Trillion-Dollar Market Is Taking Shape – Are you in?

GET INVOLVED

THE WORLD’S MOST
EXTREME LIVING LAB.

UAE isn’t just a venue. It’s the dataset.

Nowhere on earth offers a more extreme, diverse, and instrumented population for longevity research.
And no government is more willing to co-build the future around your science.

AGILE REGULATIONS & SANDBOX ENVIRONMENTS

RICH REPOSITORY OF HIGH-VALUE DATA

STRATEGIC & SWIFT INVESTMENT DEPLOYMENT

INTEGRATED
ECOSYSTEM

GET YOUR TICKET

#

Sugar Consumption Per Capita

+

Nationalities in One Country

°C

Extreme Heat Stress Conditions

Uncontrolled Peptide Market

PM2.5

Urban Air Pollution Profile

%

Desalinated Water Supply

GET INVOLVED

$ Billion+

Direct and indirect annual economic impact of deploying AI and tech in biotech and preventive health.

Million

Emirati genome sequencing target – the largest genome sequencing program in the world.

$ Billion+

UAE biotech economy that includes biological systems, R&D, bio innovation and technology that improve human health.

LEADERS SPEAK

Our investments in the industries of the future, particularly at the intersection of AI, biotech, and preventive health, are a cornerstone of our new economy. The UAE is committed to creating the infrastructure and regulatory environment to turn scientific research into economic value, making longevity and better health a key driver of our national GDP.

H.E. ABDULLA BIN TOUQ AL MARRI

Minister of Economy

Through investment in digital transformation and innovation, we continue to work collectively with partners across public and private sectors to solidify the UAE’s position as a global model for comprehensive healthcare and to achieve the national goal of ranking among the top 15 healthcare systems worldwide by 2031.

H.E. Ahmed bin Ali Al Sayegh

Minister of Health & Prevention

GET YOUR PASS

STRATEGIC PROGRAMS FOR MAXIMUM IMPACT

THE WORLD LONGEVITY FORUM – MAIN STAGE

The Moment Longevity and Tech Become Same Conversation

THE FRONTIER ZONE – THE WEIRD SCIENCE STAGE

Moonshots, Demos, Debates—No Boring Panels

THE COMPUTE ZONE- TEACHING MACHINES TO CURE DEATH

Closing the compute-to-clinic gap with partnerships

THE GULF “PROBLEM SANDBOX” ASSET

The Gulf is a real-world “stress-test” cohort—rich in digital health data and biological signal—ideal for uncovering next-generation metabolic and longevity targets.

THE BREAKTHROUGH ZONE

Livx’s daily spotlight on the Gulf’s hardest ageing accelerators—Air, Compounds, Sugar & Water

UAE-BIOTECH BUSINESS FORUM

Closed‑Door Biotech Growth Forum: Regulators, Investors, Scaleups

JOIN AS A SPONSOR GET YOUR PASS

Who Exhibits at LivX

Biotech and life science innovators

AI health and digital health platforms

Longevity and preventive health solutions

Wellness, performance, and healthspan brands

Research institutions and healthcare operators

BOOK A SPACE

Who Attends LivX

Global investors and sovereign funds

Government and regulatory authorities

Hospitals, clinics, and healthcare networks

Researchers, scientists, and academia

Corporates, scale-ups, and global partners

GET YOUR PASS

GITEX
CONVERGENCE

LIVX is hosted alongside GITEX Global, converging worlds biggest ecosystem of tech companies and investors fund.

+

Attending Professionals

Hours of content

&

Exhibiting Startups

*

Exhibiting Companies

+

Global Investors

*

Government Entities

INVESTOR CIRCLE

LIVX brings together sovereign funds, institutional investors, VCs, and family offices investing in longevity, healthcare technology, life sciences, biotechnology, AI & age technology, medical technology, and wellness.

GET INVOLVED

Be Part of the Platform Shaping the Future of Health

The UAE offers one of the world’s most progressive environments for Whether you’re an innovator, investor, policymaker, or partner; Liv offers multiple ways to participate, showcase, and scale.

BOOK A STAND BOOK A STARTUP POD GET YOUR PASS

MEDIA PARTNERS

FAQs

What is LIVX? +

LIVX is a global platform uniting biotech, life sciences, longevity, AI and Age Tech to accelerate partnerships, validation and scale.

When and where is LIVX happening? +

LIVX takes place from 8–10 December 2026 at Expo City Dubai.

Who should attend? +

LIVX is built for investors, regulators, healthcare leaders, researchers, corporates, scale-ups and global partners shaping the future of health.

Who should exhibit? +

The event is ideal for innovators across biotech, digital health, life sciences, pharma, longevity, AI health, wellness and research.

Why LIVX? +

Because LIVX brings together the full health innovation ecosystem — from science and regulation to capital and commercialisation — in one platform.

Is LIVX part of GITEX? +

LIVX is hosted alongside GITEX Global, connecting health innovation with one of the world’s most powerful tech ecosystems.

How can I get involved? +

You can book a stand, book a startup pod, pre-register to attend, or enquire about sponsorship and partnerships.

Is attendance open to everyone? +

No. Entry is restricted to trade and business professionals, and access is limited to those over

THE LARGEST & MOST INTERNATIONAL
CROSS-INDUSTRIAL, TECH & STARTUP EVENT

GITEX host the largest network of relationships globally with public & private sectors in the internationl digital economy. GITEX brings
together 587,500+ Tech & Business Executives, 17,800+ global tech firms and 10,443+ startups from 189 countries.

CONVERGING THE MOST INFLUENTIAL ECOSYSTEM TO ACCELERATE INNOVATION AND INVESTMENT IN LONGEVITY, BIOTECH AND HEALTH TECH